Trial Profile
An Exploratory Cognition Study Conducted as an add-on to Clinical Trial 11286, to Evaluate the Neurocognitive Effects of 12 Weeks Treatment With Sertindole and Olanzapine in Patients With Schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs Sertindole (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 10 Oct 2008 New trial record.